HEADER HYDROLASE 30-JAN-92 1GLY OBSLTE 01-NOV-94 1GLY 3GLY TITLE CRYSTAL STRUCTURE OF GLUCOAMYLASE FROM ASPERGILLUS AWAMORI TITLE 2 VAR. X100 TO 2.2 ANGSTROMS RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE:; COMPND 3 CHAIN: NULL; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1 KEYWDS HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR A.ALESHIN,A.GOLUBEV,L.M.FIRSOV,R.B.HONZATKO REVDAT 2 01-NOV-94 1GLY 3 OBSLTE REVDAT 1 31-JAN-94 1GLY 0 JRNL AUTH A.ALESHIN,A.GOLUBEV,L.M.FIRSOV,R.B.HONZATKO JRNL TITL CRYSTAL STRUCTURE OF GLUCOAMYLASE FROM ASPERGILLUS JRNL TITL 2 AWAMORI VAR. X100 TO 2.2 ANGSTROMS RESOLUTION JRNL REF J.BIOL.CHEM. V. 267 19291 1993 JRNL REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.ALESHIN,A.GOLUBEV,L.M.FIRSOV,R.B.HONZATKO REMARK 1 TITL CRYSTAL STRUCTURE OF GLUCOAMYLASE FROM ASPERGILLUS REMARK 1 TITL 2 AWAMORI VAR. X100 TO 2.2 ANGSTROMS RESOLUTION REMARK 1 REF J.BIOL.CHEM. V. 267 19291 1992 REMARK 1 REFN ASTM JBCHA3 US ISSN 0021-9258 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ 1GLY REMARK 3 AUTHORS : KONNERT,HENDRICKSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : NULL REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : NULL REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3562 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 232 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.014 ; NULL REMARK 3 ANGLE DISTANCE (A) : 0.029 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.013 ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.138 ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.222 ; NULL REMARK 3 MULTIPLE TORSION (A) : 0.157 ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 2.300 ; NULL REMARK 3 STAGGERED (DEGREES) : 13.900; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1GLY COMPLIES WITH FORMAT V. 2.3, 09-JULY-1998 REMARK 5 REMARK 5 1GLY RESIDUE ASN 171 IS BOUND TO A CARBOHYDRATE CHAIN AS REMARK 5 SHOWN 1GLY BELOW: 1GLY ALPHA-1->3-MAN 1GLY | 1GLY ASN 171- REMARK 5 GLCNAC-BETA-1->4-GLCNAC-BETA-1->4-MAN 1GLY 1GLY REMARK 6 REMARK 6 1GLY RESIDUE ASN 395 IS BOUND TO A CARBOHYDRATE CHAIN AS REMARK 6 SHOWN 1GLY BELOW: 1GLY ALPHA-1->3-MAN 1GLY | 1GLY ASN 395- REMARK 6 GLCNAC-BETA-1->4-GLCNAC-BETA-1->4-MAN 1GLY _______________| REMARK 6 1GLY | 1GLY ALPHA-1->6-MAN-ALPHA-1->3-MAN 1GLY 1GLY REMARK 7 REMARK 7 1GLY RESIDUES SER 443, 444, 453, 455, 459, AND 460 ARE EACH REMARK 7 1GLY BOUND TO A SINGLE MANNOSE. 1GLY REMARK 8 REMARK 8 1GLY RESIDUES THR 452, 457, 462, AND 464 ARE EACH BOUND TO REMARK 8 A 1GLY SINGLE MANNOSE. 1GLY REMARK 9 REMARK 9 1GLY FURTHER INFORMATION ON SITE IDENTIFICATION WILL BE REMARK 9 1GLY PROVIDED IN FUTURE UPDATES. THE DEPOSITORS KNOW FROM REMARK 9 1GLY INHIBITOR-ENZYME COMPLEXES, NOW UNDERGOING REFINEMENT, REMARK 9 THAT 1GLY GLU 179 AND GLU 400 ARE THE PRINCIPAL CATALYTIC REMARK 9 RESIDUES. 1GLY SIERKS ET AL. (SEE MANUSCRIPT) HAD ALREADY REMARK 9 IDENTIFIED 1GLY GLU 179 AS AN ESSENTIAL RESIDUE ON THE REMARK 9 BASIS OF EXPERIMENTS 1GLY IN DIRECTED MUTATION. DR. BIRTE REMARK 9 SVENSSON AND HER COWORKERS 1GLY ARE NOW IN THE PROCESS OF REMARK 9 MAKING MUTANTS AT POSITION 400. 1GLY REMARK 10 REMARK 10 1GLY CORRECTION. THIS ENTRY IS OBSOLETE. 01-NOV-94. 1GLY REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : NULL REMARK 200 RADIATION SOURCE : NULL REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.92 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 1/2-X,-Y,1/2+Z REMARK 290 3555 -X,1/2+Y,1/2-Z REMARK 290 4555 1/2+X,1/2-Y,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 58.35000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 24.24500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.15000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 24.24500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 58.35000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.15000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 1 CHAIN(S). SEE REMARK 350 FOR REMARK 300 INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI REMARK 500 ND2 ASN 395 C1A ASL 395 1.35 REMARK 500 OG SER 443 C1 GLC 443 1.37 REMARK 500 OG SER 459 C1 GLC 459 1.38 REMARK 500 OG SER 460 C1 GLC 460 1.38 REMARK 500 OG SER 444 C1 GLC 444 1.39 REMARK 500 OG SER 453 C1 GLC 453 1.39 REMARK 500 OG SER 455 C1 GLC 455 1.39 REMARK 500 OG1 THR 462 C1 GLC 462 1.39 REMARK 500 OG1 THR 457 C1 GLC 457 1.40 REMARK 500 OG1 THR 464 C1 GLC 464 1.40 REMARK 500 OG1 THR 452 C1 GLC 452 1.41 REMARK 500 ND2 ASN 171 C1A ASF 171 1.42 SEQRES 1 470 ALA THR LEU ASP SER TRP LEU SER ASN GLU ALA THR VAL SEQRES 2 470 ALA ARG THR ALA ILE LEU ASN ASN ILE GLY ALA ASP GLY SEQRES 3 470 ALA TRP VAL SER GLY ALA ASP SER GLY ILE VAL VAL ALA SEQRES 4 470 SER PRO SER THR ASP ASN PRO ASP TYR PHE TYR THR TRP SEQRES 5 470 THR ARG ASP SER GLY LEU VAL ILE LYS THR LEU VAL ASP SEQRES 6 470 LEU PHE ARG ASN GLY ASP THR ASP LEU LEU SER THR ILE SEQRES 7 470 GLU HIS TYR ILE SER SER GLN ALA ILE ILE GLN GLY VAL SEQRES 8 470 SER ASN PRO SER GLY ASP LEU SER SER GLY GLY LEU GLY SEQRES 9 470 GLU PRO LYS PHE ASN VAL ASP GLU THR ALA TYR THR GLY SEQRES 10 470 SER TRP GLY ARG PRO GLN ARG ASP GLY PRO ALA LEU ARG SEQRES 11 470 ALA THR ALA MET ILE GLY PHE GLY GLN TRP LEU LEU ASP SEQRES 12 470 ASN GLY TYR THR SER ALA ALA THR GLU ILE VAL TRP PRO SEQRES 13 470 LEU VAL ARG ASN ASP LEU SER TYR VAL ALA GLN TYR TRP SEQRES 14 470 ASN GLN THR GLY TYR ASP LEU TRP GLU GLU VAL ASN GLY SEQRES 15 470 SER SER PHE PHE THR ILE ALA VAL GLN HIS ARG ALA LEU SEQRES 16 470 VAL GLU GLY SER ALA PHE ALA THR ALA VAL GLY SER SER SEQRES 17 470 CYS SER TRP CYS ASP SER GLN ALA PRO GLN ILE LEU CYS SEQRES 18 470 TYR LEU GLN SER PHE TRP THR GLY SER TYR ILE LEU ALA SEQRES 19 470 ASN PHE ASP SER SER ARG SER GLY LYS ASP THR ASN THR SEQRES 20 470 LEU LEU GLY SER ILE HIS THR PHE ASP PRO GLU ALA GLY SEQRES 21 470 CYS ASP ASP SER THR PHE GLN PRO CYS SER PRO ARG ALA SEQRES 22 470 LEU ALA ASN HIS LYS GLU VAL VAL ASP SER PHE ARG SER SEQRES 23 470 ILE TYR THR LEU ASN ASP GLY LEU SER ASP SER GLU ALA SEQRES 24 470 VAL ALA VAL GLY ARG TYR PRO GLU ASP SER TYR TYR ASN SEQRES 25 470 GLY ASN PRO TRP PHE LEU CYS THR LEU ALA ALA ALA GLU SEQRES 26 470 GLN LEU TYR ASP ALA LEU TYR GLN TRP ASP LYS GLN GLY SEQRES 27 470 SER LEU GLU ILE THR ASP VAL SER LEU ASP PHE PHE LYS SEQRES 28 470 ALA LEU TYR SER GLY ALA ALA THR GLY THR TYR SER SER SEQRES 29 470 SER SER SER THR TYR SER SER ILE VAL SER ALA VAL LYS SEQRES 30 470 THR PHE ALA ASP GLY PHE VAL SER ILE VAL GLU THR HIS SEQRES 31 470 ALA ALA SER ASN GLY SER LEU SER GLU GLN PHE ASP LYS SEQRES 32 470 SER ASP GLY ASP GLU LEU SER ALA ARG ASP LEU THR TRP SEQRES 33 470 SER TYR ALA ALA LEU LEU THR ALA ASN ASN ARG ARG ASN SEQRES 34 470 SER VAL VAL PRO PRO SER TRP GLY GLU THR SER ALA SER SEQRES 35 470 SER VAL PRO GLY THR CYS ALA ALA THR SER ALA SER GLY SEQRES 36 470 THR TYR SER SER VAL THR VAL THR SER TRP PRO SER ILE SEQRES 37 470 VAL ALA FTNOTE 1 GLY 23 - ALA 24 OMEGA = 1.32 PEPTIDE BOND DEVIATES FTNOTE 1 SIGNIFICANTLY FROM TRANS CONFORMATION FTNOTE 2 CIS PROLINE - PRO 46 FTNOTE 3 CIS PROLINE - PRO 123 FTNOTE 4 RESIDUE ASN 171 IS BOUND TO A CARBOHYDRATE CHAIN AS SHOWN FTNOTE 4 BELOW: ALPHA-1->3-MAN | ASN 171-GLCNAC-BETA-1->4-GLCNAC- FTNOTE 4 BETA-1->4-MAN FTNOTE 5 RESIDUE ASN 395 IS BOUND TO A CARBOHYDRATE CHAIN AS SHOWN FTNOTE 5 BELOW: ALPHA-1->3-MAN | ASN 395-GLCNAC-BETA-1->4-GLCNAC- FTNOTE 5 BETA-1->4-MAN _______________| | ALPHA-1->6-MAN-ALPHA-1->3- FTNOTE 5 MAN FTNOTE 6 RESIDUES SER 443, 444, 453, 455, 459, AND 460 ARE EACH FTNOTE 6 BOUND TO A SINGLE MANNOSE. FTNOTE 7 RESIDUES THR 452, 457, 462, AND 464 ARE EACH BOUND TO A FTNOTE 7 SINGLE MANNOSE. HET GLC 443 11 HET GLC 444 11 HET GLC 452 11 HET GLC 453 11 HET GLC 455 11 HET GLC 457 11 HET GLC 459 11 HET GLC 460 11 HET GLC 462 11 HET GLC 464 11 HET ASF 171 50 HET ASL 395 72 HETNAM GLC GLUCOSE HETNAM ASL ASPARTIC ACID-4-CARBOXYETHYL ESTER FORMUL 2 GLC 10(C6 H12 O6) FORMUL 12 ASF FORMUL 13 ASL C7 H11 N O6 HELIX 1 H1 ALA 1 ASN 20 1 20 HELIX 2 H2 THR 53 ARG 68 1 16 HELIX 3 H3 THR 72 GLN 89 1 18 HELIX 4 H4 ASP 126 ASP 144 1 19 HELIX 5 H5 THR 148 GLN 168 1 21 HELIX 6 H6 PHE 186 ALA 205 1 20 HELIX 7 H7 SER 211 PHE 227 1 17 HELIX 8 H8 ASP 245 HIS 254 1 10 HELIX 9 H9 PRO 272 PHE 285 1 14 HELIX 10 H10 PHE 318 GLN 338 1 21 HELIX 11 H11 ASP 345 LEU 354 1NOT PART OF THE BARREL 10 HELIX 12 H12 SER 368 HIS 391 1 24 HELIX 13 H13 THR 416 ARG 429 1 14 SHEET 1 S1 2 ASN 21 GLY 23 0 SHEET 2 S1 2 GLY 35 VAL 38 -1 O ILE 36 N GLY 23 SHEET 1 S2 3 PHE 49 THR 53 0 SHEET 2 S2 3 PRO 107 ASN 110 -1 O PHE 109 N THR 51 SHEET 3 S2 3 GLU 113 TYR 116 -1 O THR 114 N ASN 110 SHEET 1 S3 2 VAL 91 ASN 93 0 SHEET 2 S3 2 GLY 96 ASP 97 -1 O GLY 96 N ASN 93 SHEET 1 S4 2 THR 173 ASP 176 0 SHEET 2 S4 2 VAL 181 GLY 183 -1 N GLY 183 O GLY 174 SHEET 1 S5 2 SER 184 SER 185 0 SHEET 2 S5 2 ALA 235 PHE 237 -1 N PHE 237 O SER 184 SHEET 1 S6 2 CYS 262 ASP 264 0 SHEET 2 S6 2 PHE 267 GLN 268 -1 N PHE 267 O ASP 264 SHEET 1 S7 2 GLY 339 THR 344 0 SHEET 2 S7 2 THR 360 SER 365 -1 N TYR 363 O LEU 341 SHEET 1 S8 2 ALA 392 ALA 393 0 SHEET 2 S8 2 GLY 396 SER 397 -1 N GLY 396 O ALA 393 SHEET 1 S9 2 LEU 398 ASP 403 0 SHEET 2 S9 2 GLY 407 LEU 415 -1 O ALA 412 N GLU 400 TURN 1 T1 VAL 29 ALA 32 DA DISTANCE 2.87 ANGSTROMS TURN 2 T2 ASP 33 ILE 36 DA DISTANCE 3.26 ANGSTROMS TURN 3 T3 ASN 93 GLY 96 DA DISTANCE 2.90 ANGSTROMS TURN 4 T4 ASP 97 SER 100 DA DISTANCE 3.10 ANGSTROMS TURN 5 T5 GLY 103 GLU 106 DA DISTANCE 3.27 ANGSTROMS TURN 6 T6 ASN 110 GLU 113 DA DISTANCE 2.95 ANGSTROMS TURN 7 T7 TYR 169 GLN 172 DA DISTANCE 3.15 ANGSTROMS TURN 8 T8 ASP 176 GLU 179 DA DISTANCE 2.98 ANGSTROMS TURN 9 T9 ASP 257 ALA 260 DA DISTANCE 3.03 ANGSTROMS TURN 10 T10 ASP 264 PHE 267 DA DISTANCE 3.20 ANGSTROMS TURN 11 T11 GLN 268 SER 271 DA DISTANCE 2.92 ANGSTROMS TURN 12 T12 TYR 289 ASN 292 DA DISTANCE 2.74 ANGSTROMS TURN 13 T13 THR 290 ASP 293 DA DISTANCE 3.11 ANGSTROMS TURN 14 T14 ASN 292 LEU 295 DA DISTANCE 3.28 ANGSTROMS TURN 15 T15 SER 296 GLU 299 DA DISTANCE 2.93 ANGSTROMS TURN 16 T16 TYR 306 ASP 309 DA DISTANCE 3.11 ANGSTROMS TURN 17 T17 SER 310 ASN 313 DA DISTANCE 2.75 ANGSTROMS TURN 18 T18 TYR 311 GLY 314 DA DISTANCE 2.75 ANGSTROMS TURN 19 T19 TYR 355 ALA 358 DA DISTANCE 2.86 ANGSTROMS TURN 20 T20 SER 364 SER 367 DA DISTANCE 3.14 ANGSTROMS TURN 21 T21 ALA 393 GLY 396 DA DISTANCE 2.91 ANGSTROMS TURN 22 T22 GLY 438 SER 441 DA DISTANCE 3.16 ANGSTROMS TURN 23 T23 GLU 439 ALA 442 DA DISTANCE 2.97 ANGSTROMS SSBOND 1 CYS 210 CYS 213 SSBOND 2 CYS 222 CYS 449 SSBOND 3 CYS 262 CYS 270 CISPEP 1 GLY 23 ALA 24 0 1.32 CISPEP 2 ASN 45 PRO 46 0 -1.65 CISPEP 3 ARG 122 PRO 123 0 -3.13 CRYST1 116.700 104.300 48.490 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008569 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009588 0.000000 0.00000 SCALE3 0.000000 0.000000 0.020623 0.00000